$BMY 3/A SEC Filings

Filed On	Filing
31 Jul 2024	Form 3/A: McMullen Michael R., Director Holds 1,000 shares of Common Stock, $0.10 par value
09 Jun 2020	Form 3/A: Bonney Michael W, Director Holds 7,189 shares of Common Stock, $0.10 par value
29 Dec 2011	Form 3/A: Cazala Beatrice J, Pres Global Comm & Pres Europe
27 Jan 2010	Form 3/A: Bancroft Charles A, Acting CFO Holds 16,660.25 shares of Common Stock, $0.10 par value
16 Dec 2009	Form 3/A: Cazala Beatrice J, Pres Global Comm & Pres Europe Holds 78,927.58 shares of Common Stock, $0.10 par value
16 Dec 2009	Form 3/A: Mcbride Anthony A, SVP HR Holds 25,610.29 shares of Common Stock, $0.10 par value
28 Oct 2009	Form 3/A: Cazala Beatrice J, Pres Global Comm & Pres Europe Holds 75,158.58 shares of Common Stock, $0.10 par value
11 May 2009	Form 3/A: Cazala Beatrice J, Pres Global Comm & Pres Europe Holds 3,130.14 shares of Common Stock, $0.10 par value
17 Feb 2009	Form 3/A: Carlo de Notaristefani, President, Tech Ops
02 Aug 2007	Form 3/A: Hooper Anthony C, President US Pharmaceuticals Holds 110,088 shares of Common Stock, $0.10 par value
09 Dec 2005	Form 3/A: Celentano John E, President, Health Care Group Holds 31,694 shares of Common Stock, $0.10 par value

Comments